abagovomab 55
abciximab 52
abituzumab 36
abrilumab 36
actoxumab 41
adalimumab 23
aducanumab 21
afasevikumab 26
alacizumab_pegol 17
alemtuzumab 48
alirocumab 27
amatuximab 62
andecaliximab 38
anifrolumab 41
anrukinzumab 21
aprutumab 29
aprutumab_ixadotin 29
arcitumomab 35
ascrinvacumab 28
atezolizumab 18
atinumab 25
avelumab 26
basiliximab 61
bavituximab 58
begelomab 54
benralizumab 46
bevacizumab_beta 27
bezlotoxumab 41
bimagrumab 40
bleselumab 42
blinatumomab 55
blosozumab 45
bococizumab 38
brazikumab 27
brentuximab_vedotin 54
briakinumab 27
brodalumab 36
brolucizumab 33
brontictuzumab 43
burosumab 42
cabiralizumab 46
camrelizumab 17
canakinumab 32
cantuzumab_ravtansin 62
carlumab 32
carotuximab 41
cergutuzumab_amunaleukin2 38
cergutuzumab_amunaleukin 38
certolizumab_pegol 29
cetiximab 54
citatuzumab_bogatox 35
cixutumumab 53
clivatuzumab_tetraxetan 39
codrituzumab 46
conatumumab 31
concizumab 38
crenezumab 28
crizanlizumab 42
crotedumab 31
dacetuzumab 26
daclizumab 33
dalotuzumab 46
dapirolizumab_pegol 30
daratumumab 18
dectrekumab 16
demcizumab 46
denosumab 15
depatuxizumab 37
depatuxizumab_mafodotin 37
dezamizumab 41
dinutuximab 51
diridavumab 40
domagrozumab 19
drozitumab 28
duligotuzumab 22
durvalumab 18
dusigitumab 45
efalizumab 40
efungumab 43
eldelumab 27
elezanumab 45
elgemtumab 17
elotuzumab 25
emactuzumab 39
emapalumab 34
emibetuzumab 37
enavatuzumab 30
enfortumab_vedotin 21
enoblituzumab 26
enokizumab 40
enoticumab 27
ensituximab 53
eptinezumab 23
erenumab 38
etaracizumab 20
etrolizumab 27
evinacumab 28
evolocumab 40
farletuzumab 13
fasinumab 40
fezakinumab 46
fibatuzumab 34
ficlatuzumab 39
firivumab 46
flanvotumab 36
fletikumab 52
foralumab 23
foravirumab 22
fremanezumab 36
fresolimumab 31
fulranumab 27
futuximab 49
galcanezumab 36
ganitumab 45
gantenerumab 22
gemetuzumab 49
gemtuzumab2 44
gemtuzumab 56
gevokizumab 38
girentuximab 42
glembatumumab 42
glembatumumab_vedotin 42
guselkumab 43
ibalizumab 39
ibritumomab 62
icrucumab 18
idarucizumab 56
ifabotuzumab 34
imalumab 20
imgatuzumab 41
inclacumab 27
indatuximab_ravtansin 46
indusatumab 33
inebilizumab 37
intetumumab 22
iodine_girentuximab 35
ipilimumab 12
iratumumab 39
isatuximab 47
itolizumab 33
ixekizumab 48
labetuzumab_govitecan 31
lambrolizumab 46
lampalizumab 37
lanadelumab 24
landogrozumab 25
laprituximab 46
lebrikizumab 46
lendalizumab 43
lenzilumab 40
lifastuzumab_vedotin 26
ligelizumab 37
lilotomab 50
lirilumab 45
lodelcizumab 41
lokivetmab 34
lorvotuzumab_mertansin 33
lucatumumab 37
lumretuzumab 36
lupartumab 27
lutikizumab 22
margetuximab 47
milatuzumab 57
mirvetuximab 53
mirvetuximab_soravtansin 53
modotuximab 64
mogamulizumab 34
monalizumab 42
motavizumab 45
moxetumomab_pasudotox 33
namilumab 43
naratuximab 51
naratuximab_emtansin 51
narnatumab 23
navicixizumab2 41
navicixizumab 47
navivumab 54
necitumumab 35
nemolizumab 45
nesvacumab 18
nivolumab 23
obiltoxaximab 40
obinutuzumab 48
ocaratuzumab 42
ofatumumab 27
olaratumab 40
olokizumab 29
omalizumab 28
onartuzumab 28
ontuxizumab 42
opicinumab 21
orticumab 20
otelixizumab 42
oxelumab 19
ozanezumab 51
pamrevlumab 17
panobacumab 31
parsatuzumab 34
pasotuxizumab 24
pateclizumab 23
patritumab 38
pembrolizumab 46
perakizumab 28
pidilizumab 36
pinatuzumab_vedotin 23
plozalizumab 35
pogalizumab 43
polatuzumab_vedotin 27
ponezumab 58
prezalumab 19
pritoxaximab 56
quilizumab 22
racotumomab 50
radretumab 21
ralpancizumab 41
ramucirumab 22
ranevetmab 37
ranibizumab 27
refanezumab 33
remtolumab 23
rilotumumab 38
rinucumab 39
risankizumab 45
rituximab 48
rivabazumab 28
robatumumab 22
roledumab 36
romosozumab 40
rontalizumab 30
rosmantuzumab 42
rozanolixizumab 26
sacituzumab 41
sacituzumab_govitecan 41
samalizumab 44
sapelizumab 41
sarilumab 24
secukinumab 25
seribantumab 24
setoxaximab 60
sifalimumab 29
siltuximab 38
simtuzumab 47
sirukumab 20
solanezumab 32
solitomab 45
stamulumab 40
suptavumab 34
suvizumab 30
tabalumab 37
tadocizumab 33
tamtuvetmab 43
tanezumab 36
tarextumab 16
tavolixizumab 33
telisotuzumab 45
teplizumab 34
tesidolumab 43
tezepelumab 38
tigatuzumab 17
tildrakizumab 41
timolumab 21
tisotumab 19
tosatoxumab 52
tositumomab 59
tralokinumab 51
trastuzumab 28
tregalizumab 28
trevogrumab 23
ublituximab 56
urelumab 42
ustekinumab 41
utomilumab 47
vadastuximab 47
vadastuximab_talirin 47
vandortuzumab_vedotin 28
vantictumab 30
vanucizumab2 27
vanucizumab 57
varlilumab 22
vatelizumab 49
vedolizumab 50
veltuzumab 40
vesencumab 18
vorsetuzumab 40
vorsetuzumab_mafodotin 40
vunakizumab 54
xentuzumab 26
zatuximab 64
